Sign in

    Avery Kriss

    Research Analyst at Wolfe Research, LLC

    Avery Kriss is an Equity Research Associate at Wolfe Research, LLC, specializing in macro research and quantitative analysis contributing to sector coverage such as Industrials, Utilities/Energy, Consumer/Retail, Financials/REITS, Healthcare, and Technology, Media, and Telecommunications. Kriss supports coverage of major companies within these sectors by leveraging alternative data and advanced stock selection models, contributing to Wolfe Research’s #6 ranking in the 2024 Extel All-America Research Poll with strong client recognition for analytic rigor and objective insights. Since joining Wolfe Research, Kriss has focused on enhancing portfolio analytics and risk management tools for institutional clients, with Wolfe’s analysts consistently ranking among the top for equity research performance. Kriss holds professional credentials in equity research, is affiliated with a top independent firm, and benefits from Wolfe’s mentoring-focused environment for ongoing development.

    Avery Kriss's questions to HOLOGIC (HOLX) leadership

    Avery Kriss's questions to HOLOGIC (HOLX) leadership • Q2 2025

    Question

    Avery Kriss, on for Doug Schenkel, asked if hospitals are delaying gantry purchases in anticipation of the new Envision system and whether the imaging business could outgrow its long-term targets next year. He also inquired about M&A priorities, particularly in broader surgical categories.

    Answer

    COO Essex Mitchell stated they are not seeing customers hold out for Envision, as the current 3Dimensions platform offers most of the same software and best-in-class care. CEO Stephen MacMillan addressed M&A, stating the company continues to look for tuck-in acquisitions across all three of its business segments (diagnostics, imaging, and surgical) and will not provide more specific details on its priorities.

    Ask Fintool Equity Research AI